# Adagene (Suzhou)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adagene-suzhou

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Website: www.adagene.com
- Total disclosed funding: $155M
- Latest round: Series D (Jan 8, 2020)
- Investors on record: 10

## About

Founded in 2012 and based in China, Adagene (Suzhou) Limited is a biotechnology company that discovers and designs innovative antibody and engineering technologies for the treatment of cancer. The company is headquartered in Suzhou and has a branch in the United States.

The firm develops a dynamic precision library (DPL) that is used to develop a unique pipeline of innovative antibody therapeutics including immuno-oncology antibodies, providing new, innovative, and more effective treatments.

The company generates revenue by providing biopharmaceutical products and related antibody-based therapies.

## Funding rounds

- Series D, Jan 8, 2020, $69M — Hong Shan, General Atlantic, Eight Roads Ventures, F-Prime Capital
- Series C, Mar 26, 2018, $50M — Hong Shan, New World TMT, King  Star Capital, Avic Trust, Gopher Asset Management
- Series B, Jan 28, 2016, $28M — Eight Roads Ventures, F-Prime Capital, GP Capital, 6 Dimensions Capital, New World TMT
- Series A, Dec 8, 2014, $8M — Eight Roads Ventures, F-Prime Capital, 6 Dimensions Capital

## Investors

- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A, Series B, Series D
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B, Series D
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A, Series B
- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series B
- New World TMT — Series B, Series C
- Hong Shan — Series C, Series D
- King  Star Capital — Series C
- Avic Trust (https://capitalatlas.ai/funds/avic-trust) — Series C
- Gopher Asset Management (https://capitalatlas.ai/funds/gopher-asset-management) — Series C
- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Series D